Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT00031759
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed primary grade II or III cervical intraepithelial neoplasia (CIN) or persistent grade I-III CIN (dysplasia that is not new and requires treatment)
* Squamous cell lesions not involving endocervix by colposcopy OR colposcopy with negative cytobrush or endocervical curettage
* No untreated cervical or vaginal infection other than human papilloma virus
* No desire for hysterectomy as ablative therapy
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Life expectancy:
* At least 5 years
Other:
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception during and for 3 months after study
* HIV negative
* No AIDS
* No known hypersensitivity to imiquimod
* No latex allergy
PRIOR CONCURRENT THERAPY:
Other:
* No concurrent immunosuppressive therapy
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00031759
Study Brief:
Protocol Section:
NCT00031759